RAMP
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88169723
- Registration number
- 6411753
- Mark type
- Stylized text
- Filed
- 25 Oct 2018
- Published for opposition
- 09 Apr 2019
- Registered
- 06 Jul 2021
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug research and design services which allow for technological design and development of small-molecule pharmaceuticals with pre-determined pharmacology
Owner
- ABLI THERAPEUTICS, INC., ATLANTA, GA, US
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
- Inhibikase Therapeutics, Inc., Atlanta, GA, US
Prosecution history
- 04 Jun 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Apr 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Apr 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Jun 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jun 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Jun 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Jun 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 02 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 May 2021 — STATEMENT OF USE PROCESSING COMPLETE